Below are helpful summaries of recent NIH Notices. Please read and redistribute as you feel appropriate.
Questions regarding these Notices should be directed to your Contract and Grant Officer.
NOT-IC-AT-005 – NCCIH Policy for Submission of R15 Applications Containing Clinical Trials
The purpose of this Notice is to define the types of clinical studies that NCCIH will support through PA-13-313 "Academic Research Enhancement Award (Parent R15)" and subsequent reissuances of this Funding Opportunity Announcement (FOA). After May 7, 2015, NCCIH will not accept R15 applications which include clinical trials to Parent R15 FOA. This policy does not apply to other NCCIH-specific announcements that specifically solicit clinical trials.
NOT-HL-15-256 – Notice of Change to Award Information Regarding Allowable Requested Direct Costs in PAR-13-316 "NHLBI Program Project Applications (P01)"
This Notice provides updated information regarding allowable requested direct costs in PAR-13-316 "NHLBI Program Project Applications (P01)". NHLBI guidelines for Allowable Requested Direct Costs for Program Project Grants (P01s) have been revised to clarify that renewal (Type 2) P01 applications may request up to the direct cost (excluding first-tier subcontract Facilities and Administrative [F&A] costs) awarded for the last noncompetitive segment.
Director, Sponsored Projects
Sponsored Projects Administration
UCI Office of Research
5171 California Avenue, Suite 150
Irvine, CA 92697-7600
PH: (949) 824-2897
Fax: (949) 824-2094
Normal hours: 8:30am-6:30pm
1st/3rd Thursday: 8:30am-5:30pm
1st/3rd Friday: Out of office